Research Article

Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia

Table 5

Antimicrobial sensitivity pattern of Gram negative bacteria isolated from urine culture of ART and non-ART user patients, Jimma University Specialized Hospital, Ethiopia, 2012.

Isolated bacteriaSensitivity patternAntimicrobial agent number (%)
NORCCROAMPNAFSXT

ART user
E.  coli ( )S21 (84)24 (96)25 (100)3 (12)12 (48)25 (100)1 (4)
R4 (16)1 (4)0 (0)22 (88)13 (52)0 (0)24 (96)
E.  aerogenes ( )S5 (83.3)6 (100)6 (100)2 (33.3)4 (66.7)6 (100)0 (0)
R1 (16.70 (0)0 (0)4 (66.7)2 (33.3)0 (0)6 (100)
K.  rhinoscleromatis ( )S1 (50)2 (100)2 (100)1 (50)1 (50)2 (100)0 (0)
R1 (50)0 (0)0 (0)1 (50)1 (50)0 (0)2 (100)
P.  alcalifaciens ( )S2 (66.7)1 (33.7)3 (100)0 (0)0 (0)2 (66.7)1 (33.3)
R1 (33.3)2 (66.7)0 (0)3 (100)3 (100)1 (33.3)2 (66.7)
Edwardsiella spp. ( )S2 (100)2 (100)2 (100)0 (0)2 (100)2 (100)1 (50)
R0 (0)0 (0)0 (0)2 (100)0 (0)0 (0)1 (50)
P.  aeruginosa ( )S1 (100)1 (100)1 (100)1 (100)1 (100)0 (0)1 (100)
R0 (0)0 (0)0 (0)0 (0)0 (0)1 (100)0 (0)
K.  pneumoniae ( )S1 (100)1 (100)1 (100)0 (0)1 (100)1 (100)1 (100)
R0 (0)0 (0)0 (0)1 (100)0 (0)0 (0)0 (0)
 Total ( )S33 (82.5)37 (92.5)40 (100)7 (17.5)21 (52.5)38 (95)5 (12.5)
R7 (17.5)3 (7.5)0 (0)33 (82.5)19 (47.5)2 (5)35 (87.5)
Non-ART user
E.  coli ( )S4 (66.7)4 (66.7)5 (83.3)0 (0)2 (33.3)6 (100)1 (16.7)
R2 (33.3)2 (33.3)1 (16.7)6 (100)4 (66.7)0 (0)5 (83.3)
K.  rhinoscleromatis ( )S1 (50)2 (100)2 (100)0 (0)1 (50)2 (100)0 (0)
R1 (50)0 (0)0 (0)2 (100)1 (50)0 (0)2 (100)
P.  alcalifaciens ( )S1 (100)1 (100)1 (100)1 (100)1 (100)1 (100)1 (100)
R0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
 Total ( )S6 (66.7)7 (77.8)8 (88.9)1 (11.1)4 (44.4)9 (100)2 (22.2)
R3 (33.3)2 (22.2)1 (11.1)8 (88.9)5 (55.6)0 (0)7 (77.7)

NOR: norfloxacin; C: ceftriaxone; CRO: chloramphenicol; AMP: ampicillin; NA: nalidixic acid; SXT: trimethoprim-sulfamethoxazole; F: nitrofurantoin.